Home
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Novo Nordisk Articles
Popular Novo Nordisk Articles
Highly Recommended Novo Nordisk Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
Thanks But No Thanks
Novartis and Novo Discontinue Their Relationship in Drug's Development
On October 29, 2001, Novo Nordisk announced it will continue the development of its dual-acting insulin sensitizer without the involvement of Novartis Pharma. The insulin sensitizer, called NN622, is currently in development for the treatment of type 2 diabetes.
Lars Rebien Sorensen, president and chief executive officer of Novo Nordisk, said: "Our development program for NN622 continues unaffected by Novartis's decision. Initiation of the phase 3 program is progressing according to schedule. Results from our phase 2 studies confirmed that the profile of NN622 meets the therapeutic objectives we had set. In terms of commercialization of the product in North America we will now be considering various alternatives."
Novartis, on the other hand, is saying that NN622 failed phase 2 criteria, according to Reuters. Thomas Ebeling, head of the Swiss group's drugs division, declined to say whether the problem was related to the product's safety profile.
"We have an ambitious product profile which includes efficacy and safety, and our assessment after having looked at the phase 2 data simply was that this product does not meet that target profile."
Reuters reports that Novartis's decision to pull out of plans to commercialize NN622 came less than a week after GlaxoSmithKline stopped development of a similar drug because of adverse side effects.
Categories: Diabetes, Diabetes, Insulin, Novo Nordisk, Type 2 Issues
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...